{"id":287087,"date":"2025-11-28T01:26:11","date_gmt":"2025-11-28T01:26:11","guid":{"rendered":"https:\/\/www.newsbeep.com\/uk\/287087\/"},"modified":"2025-11-28T01:26:11","modified_gmt":"2025-11-28T01:26:11","slug":"determining-the-value-of-genomics-in-healthcare","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/uk\/287087\/","title":{"rendered":"Determining the value of genomics in healthcare"},"content":{"rendered":"

Stark, Z. et al. Integrating genomics into healthcare: a global responsibility. Am. J. Hum. Genet 104, 13\u201320 (2019).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Sheikh Hassani, M. et al. Virtual gene panels have a superior diagnostic yield for inherited rare diseases relative to static panels. Clin. Chem. 71, 169\u2013184 (2025).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Wojcik, M. H. et al. Genome sequencing for diagnosing rare diseases. N. Engl. J. Med. 390, 1985\u20131997 (2024).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Dai, P. et al. Recommendations for next generation sequencing data reanalysis of unsolved cases with suspected Mendelian disorders: a systematic review and meta-analysis. Genet. Med. 24, 1618\u20131629 (2022).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Martyn, M. et al. Offering complex genomic screening in acute pediatric settings: Family decision-making and outcomes. Genet. Med. 27, 101327 (2024).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Leong, I. U. S. et al. Large-scale pharmacogenomics analysis of patients with cancer within the 100,000 Genomes Project combining whole-genome sequencing and medical records to inform clinical practice. J. Clin. Oncol. 43, 682\u2013693 (2025).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Chen, Y. et al. De novo variants in the RNU4-2 snRNA cause a frequent neurodevelopmental syndrome. Nature 632, 832\u2013840 (2024).<\/p>\n

Clark, M. M. et al. Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseases. NPJ Genom. Med. 3, 16 (2018).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Kohler, J. N., Turbitt, E. & Biesecker, B. B. Personal utility in genomic testing: a systematic literature review. Eur. J. Hum. Genet 25, 662\u2013668 (2017).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Best, S. et al. Clinical genomic testing: what matters to key stakeholders?. Eur. J. Hum. Genet. 28, 866\u2013873 (2020).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Pollard, S. et al. Toward the diagnosis of rare childhood genetic diseases: what do parents value most?. Eur. J. Hum. Genet. 29, 1491\u20131501 (2021).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Smith, H. S. et al. Conceptualization of utility in translational clinical genomics research. Am. J. Hum. Genet. 108, 2027\u20132036 (2021).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Smith, H. S. et al. Key drivers of family-level utility of pediatric genomic sequencing: a qualitative analysis to support preference research. Eur. J. Hum. Genet. 31, 445\u2013452 (2023).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

ACMG Board of Directors. Clinical utility of genetic and genomic services: a position statement of the American College of Medical Genetics and Genomics. Genet. Med. 17, 505\u2013507 (2015).<\/p>\n

Article<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Norris, S., Belcher, A., Howard, K. & Ward, R. L. Evaluating genetic and genomic tests for heritable conditions in Australia: lessons learnt from health technology assessments. J. Community Genet. 13, 503\u2013522 (2022).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Ellard, S. et al. Rare disease genomic testing in the UK and Ireland: promoting timely and equitable access. J. Med. Genet. 61, 1103\u20131112 (2024).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Expert Meeting on Accelerating Access to Human Genomics for Public Health Participants. Accelerating access to human genomics for public health: perspectives from the Western Pacific region. Lancet Reg. Health West Pac. 53, 101265 (2024).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Wu, Y. et al. Parental health spillover effects of paediatric rare genetic conditions. Qual. Life Res. 29, 2445\u20132454 (2020).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

National Institute for Health and Care Excellence. Modular update to NICE manuals: health inequalities. https:\/\/www.nice.org.uk\/process\/pmg36\/documents\/supporting-documentation-3<\/a> (2025).<\/p>\n

Hayeems, R. Z. et al. Clinical utility of genomic sequencing: a measurement toolkit. NPJ Genom. Med. 5, 56 (2020).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Mallett, A., Stark, Z., Fehlberg, Z., Best, S. & Goranitis, I. Determining the utility of diagnostic genomics: a conceptual framework. Hum. Genomics 17, 75 (2023).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Chung, C. C. Y., Chu, A. T .W. & Chung, B. H. Y. A roadmap for genome projects to foster psychosocial and economic evidence to further policy and practice. Commun. Med. 5, 198 (2025).<\/p>\n

Hartley, T. et al. Evaluation of the diagnostic accuracy of exome sequencing and its impact on diagnostic thinking for patients with rare disease in a publicly funded health care system: a prospective cohort study. Genet. Med. 26, 101012 (2024).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Australian Genomics Health Alliance Acute Care Flagship; Lunke, S. et al. Feasibility of ultra-rapid exome sequencing in critically ill infants and children with suspected monogenic conditions in the Australian Public Health Care System. JAMA 323, 2503\u20132511 (2020).<\/p>\n

Article<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Lunke, S. et al. Integrated multi-omics for rapid rare disease diagnosis on a national scale. Nat. Med. 29, 1681\u20131691 (2023).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Dimmock, D. et al. Project Baby Bear: rapid precision care incorporating rWGS in 5 California children\u2019s hospitals demonstrates improved clinical outcomes and reduced costs of care. Am. J. Hum. Genet. 108, 1231\u20131238 (2021).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Grant, P. E., Pampaka, M., Payne, K., Clarke, A. & McAllister, M. Developing a short-form of the Genetic Counselling Outcome Scale: The Genomics Outcome Scale. Eur. J. Med Genet. 62, 324\u2013334 (2019).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Stark, Z. et al. Does genomic sequencing early in the diagnostic trajectory make a difference? A follow-up study of clinical outcomes and cost-effectiveness. Genet. Med. 21, 173\u2013180 (2019).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Khoury, M. J. et al. Health equity in the implementation of genomics and precision medicine: a public health imperative. Genet. Med. 24, 1630\u20131639 (2022).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

McAllister, M., Wood, A. M., Dunn, G., Shiloh, S. & Todd, C. The Genetic Counseling Outcome Scale: a new patient-reported outcome measure for clinical genetics services. Clin. Genet. 79, 413\u2013424 (2011).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Smith, H. S. et al. Clinical application of genome and exome sequencing as a diagnostic tool for pediatric patients: a scoping review of the literature. Genet. Med. 21, 3\u201316 (2019).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Pan, T., Wu, Y., Buchanan, J. & Goranitis, I. QALYs and rare diseases: exploring the responsiveness of SF-6D, EQ-5D-5L and AQoL-8D following genomic testing for childhood and adult-onset rare genetic conditions in Australia. Health Qual. Life Outcomes 21, 132 (2023).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Hayeems, R. Z. et al. The development of the Clinician-reported Genetic testing Utility InDEx (C-GUIDE): a novel strategy for measuring the clinical utility of genetic testing. Genet. Med. 22, 95\u2013101 (2020).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Hayeems, R. Z. et al. The Clinician-reported Genetic testing Utility InDEx (C-GUIDE): preliminary evidence of validity and reliability. Genet. Med. 24, 430\u2013438 (2022).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Hayeems, R. Z. et al. Assessing the performance of the Clinician-reported Genetic Testing Utility InDEx (C-GUIDE): further evidence of inter-rater reliability. Clin. Ther. 45, 729\u2013735 (2023).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Hayeems, R. Z. et al. Applying the Clinician-reported Genetic testing Utility InDEx (C-GUIDE) to genome sequencing: further evidence of validity. Eur. J. Hum. Genet. 30, 1423\u20131431 (2022).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Hayeems, R. Z. et al. The Clinician-reported Genetic Testing Utility InDEx (C-GUIDE) for Prenatal Care: initial evidence of content and construct validity. Genet. Med. 27, 101306 (2025).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Dolman, L. I. et al. The Clinician-reported Genetic Testing Utility InDEx for Neonatal Intensive Care (C-GUIDE NICU): quantifying genome-wide sequencing utility in the NICU. Genet. Med. 27, 101503 (2025).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Smith, H. S. et al. Perceived utility of genomic sequencing: qualitative analysis and synthesis of a conceptual model to inform patient-centered instrument development. Patient 15, 317\u2013328 (2022).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Smith, H. S. et al. Measuring perceived utility of genomic sequencing: Development and validation of the GENEtic Utility (GENE-U) scale for pediatric diagnostic testing. Genet. Med. 26, 101146 (2024).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Smith, H. S. et al. Measuring perceived utility of genomic sequencing: Development and validation of the GENEtic Utility (GENE-U) scale for adult screening. Genet. Med. 26, 101240 (2024).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Turbitt, E. et al. The PrU: development and validation of a measure to assess personal utility of genomic results. Genet. Med. 25, 100356 (2022).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Turbitt, E. et al. The Parent PrU: a measure to assess personal utility of pediatric genomic results. Genet. Med. 26, 100994 (2024).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Fehlberg, Z., Goranitis, I., Mallett, A. J., Stark, Z. & Best, S. Determining priority indicators of utility for genomic testing in rare disease: a Delphi study. Genet. Med. 26, 101116 (2024).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Goranitis, I. et al. A standardized measurement and valuation scale of genomic utility for policy decisions: The GUV Scale. Value Health 28, 184\u2013190 (2025).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Phillips, K. A. et al. Methodological issues in assessing the economic value of next-generation sequencing tests: many challenges and not enough solutions. Value Health 21, 1033\u20131042 (2018).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Grosse, S. D. & Khoury, M. J. What is the clinical utility of genetic testing?. Genet. Med. 8, 448\u2013450 (2006).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Grosse, S. D., Wordsworth, S. & Payne, K. Economic methods for valuing the outcomes of genetic testing: beyond cost-effectiveness analysis. Genet. Med. 10, 648\u2013654 (2008).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Regier, D. A., Friedman, J. M., Makela, N., Ryan, M. & Marra, C. A. Valuing the benefit of diagnostic testing for genetic causes of idiopathic developmental disability: willingness to pay from families of affected children. Clin. Genet. 75, 514\u2013521 (2009).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Regier, D. A., Ryan, M., Phimister, E. & Marra, C. A. Bayesian and classical estimation of mixed logit: an application to genetic testing. J. Health Econ. 28, 598\u2013610 (2009).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Ho, M. et al. A framework for incorporating patient preferences regarding benefits and risks into regulatory assessment of medical technologies. Value Health 19, 746\u2013750 (2016).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Bridges, J. F. P. et al. A roadmap for increasing the usefulness and impact of patient-preference studies in decision making in health: a good practices report of an ISPOR task force. Value Health 26, 153\u2013162 (2023).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Smith, H. S. et al. Approaches to incorporation of preferences into health economic models of genomic medicine: a critical interpretive synthesis and conceptual framework. Appl. Health Econ. Health Policy 23, 337\u2013358 (2025).<\/p>\n

Strauss, K. A. et al. Genomic diagnostics within a medically underserved population: efficacy and implications. Genet. Med. 20, 31\u201341 (2018).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Marshall, D. A. et al. The value of diagnostic testing for parents of children with rare genetic diseases. Genet. Med. 21, 2798\u20132806 (2019).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Meng, Y., Clarke, P. M. & Goranitis, I. The value of genomic testing: a contingent valuation across six child- and adult-onset genetic conditions. Pharmacoeconomics 40, 215\u2013223 (2022).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Goranitis, I., Best, S., Christodoulou, J., Stark, Z. & Boughtwood, T. The personal utility and uptake of genomic sequencing in pediatric and adult conditions: eliciting societal preferences with three discrete choice experiments. Genet. Med. 22, 1311\u20131319 (2020).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Goranitis, I., Best, S., Stark, Z., Boughtwood, T. & Christodoulou, J. The value of genomic sequencing in complex pediatric neurological disorders: a discrete choice experiment. Genet. Med. 23, 155\u2013162 (2021).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Goranitis, I., Best, S., Christodoulou, J., Boughtwood, T. & Stark, Z. Preferences and values for rapid genomic testing in critically ill infants and children: a discrete choice experiment. Eur. J. Hum. Genet. 29, 1645\u20131653 (2021).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Meng, Y. et al. The value of genomic testing in severe childhood speech disorders. Eur. J. Hum. Genet. 32, 440\u2013447 (2024).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Regier, D. A., Weymann, D., Buchanan, J., Marshall, D. A. & Wordsworth, S. Valuation of health and nonhealth outcomes from next-generation sequencing: approaches, challenges, and solutions. Value Health 21, 1043\u20131047 (2018).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Peters, R. et al. Public preferences for the value and implementation of genomic newborn screening: Insights from two discrete choice experiments in Australia. Am. J. Hum. Genet. 112, 1515\u20131527 (2025).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Regier, D. A., Friedman, J. M. & Marra, C. A. Value for money? Array genomic hybridization for diagnostic testing for genetic causes of intellectual disability. Am. J. Hum. Genet. 86, 765\u2013772 (2010).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Goranitis, I. et al. Is faster better? An economic evaluation of rapid and ultra-rapid genomic testing in critically ill infants and children. Genet. Med. 24, 1037\u20131044 (2022).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Wu, Y. et al. Genomic sequencing for the diagnosis of childhood mitochondrial disorders: a health economic evaluation. Eur. J. Hum. Genet. 30, 577\u2013586 (2022).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Downie, L. et al. Exome sequencing for isolated congenital hearing loss: a cost-effectiveness analysis. Laryngoscope 131, E2371\u2013E2377 (2021).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Jayasinghe, K. et al. Cost-effectiveness of targeted exome analysis as a diagnostic test in glomerular diseases. Kidney Int. Rep. 6, 2850\u20132861 (2021).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

O\u2019Rourke, B., Oortwijn, W. Schuller, T. & International Joint Task Group The new definition of health technology assessment:a milestone in international collaboration. Int. J. Technol. Assess. Health Care 36, 187\u2013190 (2020).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Group, N. I. S. et al. Effect of whole-genome sequencing on the clinical management of acutely ill infants with suspected genetic disease: a randomized clinical trial. JAMA Pediatr. 175, 1218\u20131226 (2021).<\/p>\n

Article<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Kingsmore, S. F. et al. A randomized, controlled trial of the analytic and diagnostic performance of singleton and trio, rapid genome and exome sequencing in ill infants. Am. J. Hum. Genet. 105, 719\u2013733 (2019).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Dimmock, D. P. et al. An RCT of rapid genomic sequencing among seriously ill infants results in high clinical utility, changes in management, and low perceived harm. Am. J. Hum. Genet. 107, 942\u2013952 (2020).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Petrikin, J. E. et al. The NSIGHT1-randomized controlled trial: rapid whole-genome sequencing for accelerated etiologic diagnosis in critically ill infants. NPJ Genom. Med. 3, 6 (2018).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Le Tourneau, C. et al. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial. Lancet Oncol. 16, 1324\u20131334 (2015).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Ceyhan-Birsoy, O. et al. Interpretation of genomic sequencing results in healthy and ill newborns: results from the BabySeq Project. Am. J. Hum. Genet. 104, 76\u201393 (2019).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Gibbs, S. N. et al. Comprehensive review on the clinical impact of next-generation sequencing tests for the management of advanced cancer. JCO Precis. Oncol. 7, e2200715 (2023).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Stark, Z. et al. Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement. Genet. Med. 19, 867\u2013874 (2017).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Tan, T. Y. et al. A head-to-head evaluation of the diagnostic efficacy and costs of trio versus singleton exome sequencing analysis. Eur. J. Hum. Genet. 27, 1791\u20131799 (2019).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Tuxen, I. V. et al. Copenhagen Prospective Personalized Oncology (CoPPO)-clinical utility of using molecular profiling to select patients to phase I trials. Clin. Cancer Res. 25, 1239\u20131247 (2019).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Von Hoff, D. D. et al. Pilot study using molecular profiling of patients\u2019 tumors to find potential targets and select treatments for their refractory cancers. J. Clin. Oncol. 28, 4877\u20134883 (2010).<\/p>\n

Article<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Weymann, D. et al. Clinical and cost outcomes following genomics-informed treatment for advanced cancers. Cancer Med. 10, 5131\u20135140 (2021).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Vissers, L. et al. A clinical utility study of exome sequencing versus conventional genetic testing in pediatric neurology. Genet. Med. 19, 1055\u20131063 (2017).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Yeung, A. et al. A cost-effectiveness analysis of genomic sequencing in a prospective versus historical cohort of complex pediatric patients. Genet. Med. 22, 1986\u20131993 (2020).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Weymann, D. et al. Early-stage economic analysis of research-based comprehensive genomic sequencing for advanced cancer care. J. Community Genet. 13, 523\u2013538 (2022).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Hernando-Calvo, A. et al. Impact on costs and outcomes of multi-gene panel testing for advanced solid malignancies: a cost-consequence analysis using linked administrative data. EClinicalMedicine 69, 102443 (2024).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Krebs, E. et al. Real-world cost-effectiveness of multi-gene panel sequencing to inform therapeutic decisions for advanced non-small cell lung cancer: a population-based study. Lancet Reg. Health Am. 40, 100936 (2024).<\/p>\n

PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Chung, C. C. Y. et al. Meta-analysis of the diagnostic and clinical utility of exome and genome sequencing in pediatric and adult patients with rare diseases across diverse populations. Genet. Med. 25, 100896 (2023).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Shickh, S., Mighton, C., Uleryk, E., Pechlivanoglou, P. & Bombard, Y. The clinical utility of exome and genome sequencing across clinical indications: a systematic review. Hum. Genet. 140, 1403\u20131416 (2021).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Kobayashi, E. S. et al. Long term follow up of children who received rapid genomic sequencing. Genet. Med. 27, 101403 (2025).<\/p>\n

Payne, K., Gavan, S. P., Wright, S. J. & Thompson, A. J. Cost-effectiveness analyses of genetic and genomic diagnostic tests. Nat. Rev. Genet. 19, 235\u2013246 (2018).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Schwarze, K., Buchanan, J., Taylor, J. C. & Wordsworth, S. Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature. Genet. Med. 20, 1122\u20131130 (2018).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Grosse, S. D. & Gudgeon, J. M. Cost or price of sequencing? Implications for economic evaluations in genomic medicine. Genet. Med. 23, 1833\u20131835 (2021).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Santos Gonzalez, F. et al. Microcosting diagnostic genomic sequencing: a systematic review. Genet. Med. 25, 100829 (2023).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Fahr, P., Buchanan, J. & Wordsworth, S. A review of health economic studies comparing traditional and massively parallel sequencing diagnostic pathways for suspected genetic disorders. Pharmacoeconomics 38, 143\u2013158 (2020).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Santos Gonzalez, F. et al. Microcosting genomics: challenges and opportunities. Genet. Med. 27, 101310 (2025).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Bourke, M. et al. The cost-effectiveness of genomic medicine in cancer control: a systematic literature review. Appl. Health Econ. Health Policy 23, 359\u2013393 (2025).<\/p>\n

Regier, D. A. et al. A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in Canada. NPJ Precis. Oncol. 6, 76 (2022).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Schmidtke, J. & Cassiman, J. J. The EuroGentest clinical utility gene cards. Eur. J. Hum. Genet. 18, 1068 (2010).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Burke, W. et al. Genetic test evaluation: information needs of clinicians, policy makers, and the public. Am. J. Epidemiol. 156, 311\u2013318 (2002).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Schilling, C. et al. Utilisation of subsidised genetic and genomic testing in a publicly funded healthcare system 2014-2023. Eur. J. Hum. Genet. 33, 1044\u20131050 (2025).<\/p>\n

Mordaunt, D. A., Dalziel, K., Goranitis, I. & Stark, Z. Uptake of funded genomic testing for syndromic and non-syndromic intellectual disability in Australia. Eur. J. Hum. Genet 31, 977\u2013979 (2023).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Douglas, M. P., Parker, S. L., Trosman, J. R., Slavotinek, A. M. & Phillips, K. A. Private payer coverage policies for exome sequencing (ES) in pediatric patients: trends over time and analysis of evidence cited. Genet. Med. 21, 152\u2013160 (2019).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Trosman, J. R. et al. Perspectives of US private payers on insurance coverage for pediatric and prenatal exome sequencing: results of a study from the Program in Prenatal and Pediatric Genomic Sequencing (P3EGS). Genet. Med. 22, 283\u2013291 (2020).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Smith, H. S. et al. Outcomes of prior authorization requests for genetic testing in outpatient pediatric genetics clinics. Genet. Med. 23, 950\u2013955 (2021).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Zion, T. N. et al. Insurance denials and diagnostic rates in a pediatric genomic research cohort. Genet. Med. 25, 100020 (2023).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Lu, C. Y. et al. Insurance coverage policies for pharmacogenomic and multi-gene testing for cancer. J. Pers. Med. 8, 19 (2018).<\/p>\n

Beinfeld, M. T., Rucker, J. A., Jenkins, N. B., de Breed, L. A. & Chambers, J. D. Variation in Medicaid and commercial coverage of cell and gene therapies. Health Policy Open 5, 100103 (2023).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Phillips, K. A. et al. US private payers\u2019 perspectives on insurance coverage for genome sequencing versus exome sequencing: a study by the Clinical Sequencing Evidence-Generating Research Consortium (CSER). Genet. Med. 24, 238\u2013244 (2022).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Smith, H. S., Sherman, M. & Cardeiro, D. Conversations with the editors: stewardship in genomic medicine-insights from health care payers at the forefront of clinical innovation and partnerships. Clin. Ther. 45, 690\u2013694 (2023).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Wiedower, J. et al. Payer perspectives on genomic testing in the United States: a systematic literature review. Genet. Med. 27, 101329 (2025).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Braithwaite, J., Churruca, K., Long, J. C., Ellis, L. A. & Herkes, J. When complexity science meets implementation science: a theoretical and empirical analysis of systems change. BMC Med. 16, 63 (2018).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Zebrowski, A. M. et al. Qualitative study of system-level factors related to genomic implementation. Genet. Med. 21, 1534\u20131540 (2019).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Best, S., Long, J. C., Gaff, C., Braithwaite, J. & Taylor, N. Investigating the adoption of clinical genomics in Australia. An Implementation Science case study. Genes 12, 317 (2021).<\/p>\n

Gaff, C. L. et al. Preparing for genomic medicine: a real world demonstration of health system change. NPJ Genom. Med. 2, 16 (2017).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Best, S., Long, J. C., Gaff, C., Braithwaite, J. & Taylor, N. Organizational perspectives on implementing complex health interventions: clinical genomics in Australia. J. Health Organ. Manag. 35, 825\u2013845 (2021).<\/p>\n

Article<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Stark, Z. et al. Australian genomics: outcomes of a 5-year national program to accelerate the integration of genomics in healthcare. Am. J. Hum. Genet. 110, 419\u2013426 (2023).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Braithwaite, J., Glasziou, P. & Westbrook, J. The three numbers you need to know about healthcare: the 60-30-10 challenge. BMC Med. 18, 102 (2020).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Khorshidi, H. A., Marshall, D., Goranitis, I., Schroeder, B. & IJzerman, M. System dynamics simulation for evaluating implementation strategies of genomic sequencing: tutorial and conceptual model. Expert Rev. Pharmacoecon. Outcomes Res. 24, 37\u201347 (2024).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Investigators, G. P. P. et al. 100,000 genomes pilot on rare-disease diagnosis in health care – preliminary report. N. Engl. J. Med. 385, 1868\u20131880 (2021).<\/p>\n

Article<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Sosinsky, A. et al. Insights for precision oncology from the integration of genomic and clinical data of 13,880 tumors from the 100,000 Genomes Cancer Programme. Nat. Med. 30, 279\u2013289 (2024).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Howley, C. et al. The expanding global genomics landscape: converging priorities from national genomics programs. Am. J. Hum. Genet. 112, 751\u2013763 (2025).<\/p>\n

Stark, Z. et al. A prospective evaluation of whole-exome sequencing as a first-tier molecular test in infants with suspected monogenic disorders. Genet. Med. 18, 1090\u20131096 (2016).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Lionel, A. C. et al. Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test. Genet. Med. 20, 435\u2013443 (2018).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Regier, D. A. et al. Real-world diagnostic outcomes and cost-effectiveness of genome-wide sequencing for developmental and seizure disorders: evidence from Canada. Genet. Med. 26, 101069 (2024).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Dragojlovic, N. et al. The composition and capacity of the clinical genetics workforce in high-income countries: a scoping review. Genet. Med. 22, 1437\u20131449 (2020).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Jenkins, B. D. et al. The 2019 US medical genetics workforce: a focus on clinical genetics. Genet. Med. 23, 1458\u20131464 (2021).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Jayasinghe, K. et al. Clinical impact of genomic testing in patients with suspected monogenic kidney disease. Genet. Med. 23, 183\u2013191 (2021).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Yanes, T. et al. Evaluation and pilot testing of a multidisciplinary model of care to mainstream genomic testing for paediatric inborn errors of immunity. Eur. J. Hum. Genet 31, 1125\u20131132 (2023).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Ma, A. et al. Genomic multidisciplinary teams: a model for navigating genetic mainstreaming and precision medicine. J. Paediatr. Child Health 60, 118\u2013124 (2024).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

McCorkell, G. et al. A national education program for rapid genomics in pediatric acute care: Building workforce confidence, competence, and capability. Genet. Med. 26, 101224 (2024).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Nisselle, A., Terrill, B., Janinski, M., Metcalfe, S. & Gaff, C. Ensuring best practice in genomics education: a scoping review of genomics education needs assessments and evaluations. Am. J. Hum. Genet. 111, 1508\u20131523 (2024).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Nisselle, A. et al. Ensuring best practice in genomics education: a theory- and empirically informed evaluation framework. Am. J. Hum. Genet. 111, 1497\u20131507 (2024).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Nightingale, K. P. et al. Evaluation of the Master\u2019s in Genomic Medicine framework: a national, multiprofessional program to educate health care professionals in NHS England. Genet. Med. 27, 101277 (2025).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Pichini, A. & Bishop, M. A nationally agreed cross-professional competency framework to facilitate genomic testing. Genet. Med. 24, 1743\u20131752 (2022).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Pichini, A., Tatton-Brown, K., Thomas, E. & Bishop, M. A cross-professional competency framework for communicating genomic results. J. Genet. Couns. 33, 222\u2013231 (2024).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Karthikeyan, A., McKee, S. & McKay, G. J. Integration of genomic medicine to mainstream patient care within the UK National Health Service. Ulster Med. J. 93, 111\u2013118 (2024).<\/p>\n

PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Berkman, J. et al. Mainstreaming cancer genomic testing: a scoping review of the acceptability, efficacy, and impact. Clin. Genet. 107, 123\u2013135 (2025).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Mackley, M. P. et al. Mainstreaming of clinical genetic testing: a conceptual framework. Genet. Med. 27, 101465 (2025).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Mordaunt, D. A. et al. The cost of proband and trio exome and genome analysis in rare disease: a micro-costing study. Genet. Med. 26, 101058 (2024).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Best, S. et al. Teamwork in clinical genomics: a dynamic sociotechnical healthcare setting. J. Eval. Clin. Pract. 27, 1369\u20131380 (2021).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Best, S. et al. The leadership behaviors needed to implement clinical genomics at scale: a qualitative study. Genet. Med. 22, 1384\u20131390 (2020).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Friedrich, B. et al. A very big challenge\u201d: a qualitative study to explore the early barriers and enablers to implementing a national genomic medicine service in England. Front. Genet. 14, 1282034 (2023).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Kirk, E. P. et al. Nationwide, couple-based genetic carrier screening. N. Engl. J. Med. 391, 1877\u20131889 (2024).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Casalino, S. et al. Genome screening, reporting, and genetic counseling for healthy populations. Hum. Genet. 142, 181\u2013192 (2023).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Stark, Z. & Scott, R. H. Genomic newborn screening for rare diseases. Nat. Rev. Genet. 24, 755\u2013766 (2023).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

McDermott, J. H., Tsakiroglou, M., Newman, W. G. & Pirmohamed, M. Pharmacogenomics in the UK National Health Service: progress towards implementation. Br. J. Clin. Pharmacol. 91, 2241\u20132250 (2025).<\/p>\n

Lennon, N. J. et al. Selection, optimization and validation of ten chronic disease polygenic risk scores for clinical implementation in diverse US populations. Nat. Med. 30, 480\u2013487 (2024).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Rehm, H. L. et al. ClinGen\u2013the Clinical Genome Resource. N. Engl. J. Med. 372, 2235\u20132242 (2015).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Rehm, H. L., Harrison, S. M. & Martin, C. L. ClinVar is a critical resource to advance variant interpretation. Oncologist 22, 1562 (2017).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Tudini, E. et al. Shariant platform: enabling evidence sharing across Australian clinical genetic-testing laboratories to support variant interpretation. Am. J. Hum. Genet 109, 1960\u20131973 (2022).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Stark, Z. et al. Scaling national and international improvement in virtual gene panel curation via a collaborative approach to discordance resolution. Am. J. Hum. Genet. 108, 1551\u20131557 (2021).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

DiStefano, M. T. et al. The Gene Curation Coalition: a global effort to harmonize gene-disease evidence resources. Genet. Med. 24, 1732\u20131742 (2022).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Stark, Z. et al. A call to action to scale up research and clinical genomic data sharing. Nat. Rev. Genet. 26, 141\u2013147 (2025).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Rehm, H. L. et al. GA4GH: international policies and standards for data sharing across genomic research and healthcare. Cell. Genom. 1, 100029 (2021).<\/p>\n

Roberts, M. C., Kennedy, A. E., Chambers, D. A. & Khoury, M. J. The current state of implementation science in genomic medicine: opportunities for improvement. Genet. Med. 19, 858\u2013863 (2017).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Chambers, D. A., Feero, W. G. & Khoury, M. J. Convergence of implementation science, precision medicine, and the learning health care system: a new model for biomedical research. JAMA 315, 1941\u20131942 (2016).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Moullin, J. C. et al. Ten recommendations for using implementation frameworks in research and practice. Implement. Sci. Commun. 1, 42 (2020).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Brown, H. L., Sherburn, I. A., Gaff, C., Taylor, N. & Best, S. Structured approaches to implementation of clinical genomics: a scoping review. Genet Med 24, 1415\u20131424 (2022).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Curran, G. M., Bauer, M., Mittman, B., Pyne, J. M. & Stetler, C. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med. Care 50, 217\u2013226 (2012).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Taylor, N. et al. Aligning intuition and theory: a novel approach to identifying the determinants of behaviours necessary to support implementation of evidence into practice. Implement. Sci. 18, 29 (2023).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Best, S. et al. Learning from scaling up ultra-rapid genomic testing for critically ill children to a national level. NPJ Genom. Med. 6, 5 (2021).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Cheng, L. et al. Optimising the mainstreaming of renal genomics: Complementing empirical and theoretical strategies for implementation. Eur. J. Hum. Genet. 33, 351\u2013359 (2025).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Best, S. et al. Using a theory informed approach to design, execute, and evaluate implementation strategies to support offering reproductive genetic carrier screening in Australia. BMC Health Serv. Res. 23, 1276 (2023).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Fehlberg, Z. et al. Scaling-up and future sustainability of a national reproductive genetic carrier screening program. NPJ Genom. Med. 8, 18 (2023).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Best, S., Long, J. C., Braithwaite, J. & Taylor, N. Standardizing variation: Scaling up clinical genomics in Australia. Genet. Med. 25, 100109 (2023).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Laskowski, N. M. et al. Variation exists in service delivery: similarities and differences in the provision of a whole genome sequencing service for paediatric rare disease patients in the National Health Service in England. Public Health Genomics 28, 1\u201318 (2025).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Best, S., Vidic, N., An, K., Collins, F. & White, S. M. A systematic review of geographical inequities for accessing clinical genomic and genetic services for non-cancer related rare disease. Eur. J. Hum. Genet. 30, 645\u2013652 (2022).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Casauria, S. et al. Assessing the unmet needs of genomic testing in Australia: a geospatial exploration. Eur. J. Hum. Genet. 33, 496\u2013503 (2024).<\/p>\n

Pichler, F. B. et al. An operationalization framework for lifecycle health technology assessment: a Health Technology Assessment International Global Policy Forum Task Force report. Int. J. Technol. Assess. Health Care 40, e45 (2024).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Makady, A., de Boer, A., Hillege, H., Klungel, O. & Goettsch, W. What is real-world data? A review of definitions based on literature and stakeholder interviews. Value Health 20, 858\u2013865 (2017).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Sterrantino, A. F. Observational studies: practical tips for avoiding common statistical pitfalls. Lancet Reg. Health Southeast Asia 25, 100415 (2024).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Weymann, D., Krebs, E. & Regier, D. A. Addressing immortal time bias in precision medicine: practical guidance and methods development. Health Serv. Res. 60, e14376 (2025).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Hernan, M. A., Sauer, B. C., Hernandez-Diaz, S., Platt, R. & Shrier, I. Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses. J. Clin. Epidemiol. 79, 70\u201375 (2016).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Pollard, S. et al. Defining a core data set for the economic evaluation of precision oncology. Value Health 25, 1371\u20131380 (2022).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

McPhail, M., McCabe, C., Regier, D. A. & Bubela, T. The importance of and challenges with adopting life-cycle regulation and reimbursement in Canada. Health. Policy 17, 81\u201390 (2022).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Maggio, L. A., Villalba, K., German, D., Kanter, S. L. & Collard, H. R. Defining the learning health care system: an international health system leadership perspective. Acad. Med. 99, 215\u2013220 (2024).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Meghea, C. I. et al. An NIH investment in health equity – the economic impact of the Flint Center for Health Equity Solutions. BMC Public Health 21, 1774 (2021).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Hock, D. H. et al. Untargeted proteomics enables ultra-rapid variant prioritisation in mitochondrial and other rare diseases. Genome Med. 17, 58 (2025).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Tambuyzer, E. et al. Therapies for rare diseases: therapeutic modalities, progress and challenges ahead. Nat. Rev. Drug Discov. 19, 93\u2013111 (2020).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Chung, C. C. Y., Chu, A. T. W. & Chung, B. H. Y. A roadmap for genome projects to foster psychosocial and economic evidence to further policy and practice. Commun. Med. 5, 198 (2025).<\/p>\n

Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n","protected":false},"excerpt":{"rendered":"Stark, Z. et al. Integrating genomics into healthcare: a global responsibility. Am. J. Hum. Genet 104, 13\u201320 (2019).…\n","protected":false},"author":2,"featured_media":287088,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[43],"tags":[3251,5082,76807,3250,102,47813,3248,2960,7925,7924,7926,7927,56,54,55],"class_list":["post-287087","post","type-post","status-publish","format-standard","has-post-thumbnail","category-healthcare","tag-biomedicine","tag-cancer-research","tag-clinical-genetics","tag-general","tag-health","tag-health-care-economics","tag-health-policy","tag-healthcare","tag-infectious-diseases","tag-metabolic-diseases","tag-molecular-medicine","tag-neurosciences","tag-uk","tag-united-kingdom","tag-unitedkingdom"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts\/287087","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/comments?post=287087"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts\/287087\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/media\/287088"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/media?parent=287087"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/categories?post=287087"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/tags?post=287087"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}